BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Shen M, Ferens D, Broughton BRS, Murthi P, Saini S, Widdop RE, Ricardo SD, Pinar AA, Samuel CS. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension. Br J Pharmacol 2021;178:1164-81. [PMID: 33450051 DOI: 10.1111/bph.15361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Samuel CS, Bennett RG. Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions. Biochem Pharmacol 2021;197:114884. [PMID: 34968489 DOI: 10.1016/j.bcp.2021.114884] [Reference Citation Analysis]
2 Coentro JQ, May U, Prince S, Zwaagstra J, Ritvos O, Järvinen TAH, Zeugolis DI. Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies. Front Bioeng Biotechnol 2021;9:756399. [PMID: 34765594 DOI: 10.3389/fbioe.2021.756399] [Reference Citation Analysis]
3 Li Y, Chakraborty A, Broughton BRS, Ferens D, Widdop RE, Ricardo SD, Samuel CS. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice. Biomed Pharmacother 2021;144:112256. [PMID: 34607108 DOI: 10.1016/j.biopha.2021.112256] [Reference Citation Analysis]
4 Xia C, Shao L, Ma Y, Wang X, Zhang Y, Shi C, Li H, Wang J. Ultrasound-Guided Transplantation of Mesenchymal Stem Cells Improves Adriamycin Nephropathy in Rats Through the RIPK3/MLKL and TLR-4/NF-κB Signaling. Stem Cells Dev 2021;30:1003-16. [PMID: 34486384 DOI: 10.1089/scd.2021.0087] [Reference Citation Analysis]